Jess Roper's Restricted Stock Grant in Revelation Biosciences, Inc.

On October 29, 2025, Jess Roper, a director of Revelation Biosciences, Inc., was granted 15,625 shares of common stock under the 2021 Equity Incentive Plan. The shares were granted at a price of $1.28 per share and are set to vest 100% on January 28, 2026. Following this transaction, Roper's total holdings in the company increased to 15,686 shares. This filing, submitted on October 30, 2025, details the transaction and Roper's updated ownership status.